New stainless steel access interlock prevents accidental lock-in in dangerous areas
SERV Trayvou Interverrouillage (STI) has launched the NXO1LTC, a new access interlock with personnel key for harsh or corrosive environments
To gain access to a dangerous area, the operator has to first insert an isolation key into the lock portion. Turning this key releases the personnel key, and allows the bolt to be removed and the door opened.
The operator retains the personnel key while inside the dangerous area. This prevents the door being shut behind them and also stops the machine from being restarted by another person.
The NXO1LTC’s completely stainless steel construction makes it suitable for use in harsh or corrosive environments as the paper, food, robotic, chemical and petrochemical industries.
As an entirely mechanical proposition, the NXO1LTC removes the need for cabling, reducing related maintenance costs and eliminating the risk of a cable malfunction.
STI’s safety products are heavy-duty and comply with all European machinery directives currently in force. They are popular with customers due to their strength and simple method of operation.
You may also like
Manufacturing
Lonza appoints Hans Trees as Global Head of Communications
Read moreHans Trees will join Lonza as Global Head of Communications, Senior Vice President and Member of the Extended Executive Committee, effective 1 September 2026. Hans combines deep industry experience with a strong track record in stakeholder engagement, most recently serving as Global Head of External Engagement at Roche
Trending Articles
-
You need to be a subscriber to read this article.
Click here to find out more.
You may also like
Manufacturing
Lonza appoints Hans Trees as Global Head of Communications
Hans Trees will join Lonza as Global Head of Communications, Senior Vice President and Member of the Extended Executive Committee, effective 1 September 2026. Hans combines deep industry experience with a strong track record in stakeholder engagement, most recently serving as Global Head of External Engagement at Roche
Manufacturing
AlzeCure licenses Alzheimer’s candidate ACD680 to Lilly in deal worth up to $1bn
AlzeCure Pharma has entered a global licensing and collaboration agreement with Eli Lilly for its Alzheimer's disease candidate ACD680, securing a $10m upfront payment and potential milestone payments exceeding $1bn
Manufacturing
Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference
By taking a three-tiered approach to protecting patients and personnel and ensuring plant compliance, GEA adopts a consultative approach to helping its customers navigate the responsibilities of pharmaceutical manufacturing safety with confidence
Manufacturing
Aragen to manufacture Renaissance Pharma’s FDA Fast Track mAb as part of ongoing strategic collaboration
CRDMO successfully scaled and transferred Renaissance Pharma’s lead candidate, Daretabart a humanised monoclonal antibody targeting GD2 for high-risk neuroblastoma, in just 9 months
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Regulatory
NICE approval is not enough: why the UK’s next medicines challenge is operational delivery
A medicine is not truly accessible until it can be manufactured, procured, stocked, prescribed, dispensed and delivered reliably. That distinction is becoming increasingly important, says Varun Cruz, founder of NEUVIOR